Edited by
George Vande Woude, Director, Van Andel Research Institute, Grand Rapids, MI, USA
George Klein, Karolinska Insitutet, Stockholm, Sweden
Description
The
Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer
research. This volume presents outstanding and original reviews on a variety of topics including NY-ESO-1: review of an immunogenic tumor
antigen; Order, disorder, death: lessons from a superorganism; Control of differentiation in progression of epithelial tumors; Cancer
vaccines: preclinical studies and novel strategies; Clinical results of vaccine therapy for cancer: learning from history for improving
the future; Immunodominance and immunodomination: critical factors in developing effective CD8+ T-cell based cancer vaccines; NK cell
receptors as tools in cancer immunotherapy; Innate immune recognition and suppression of tumors; Inhibitors of the HSP90 molecular chaperone:
current status.
Included in series
Advances in Cancer Research
Audience:
Researchers and students in the basic and clinical science of cancer biology and oncology, plus related areas in genetics, immunology, pharmacology, cell biology and molecular biology.
